XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Nov 09, 2021 | Option Exercise | $29.37 | 4,500 | 132,165 | 23,423 | Nov 12, 2021, 04:15 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | EVP, Chief Commercial Officer | Sep 27, 2021 | Sale | $107.81 | 10,000 | 1,078,050 | 23,509 | Sep 27, 2021, 07:21 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Sep 23, 2021 | Sale | $99.99 | 39,260 | 3,925,511 | 30,311 | Sep 24, 2021, 07:36 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Sep 24, 2021 | Sale | $100.51 | 10,740 | 1,079,491 | 16,051 | Sep 24, 2021, 07:36 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Sep 21, 2021 | Sale | $91.31 | 13,300 | 1,214,457 | 25,573 | Sep 22, 2021, 06:08 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | EVP, Chief Commercial Officer | Sep 21, 2021 | Option Exercise | $95.32 | 10,000 | 953,200 | 23,509 | Sep 22, 2021, 05:56 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Sep 07, 2021 | Option Exercise | $129.36 | 587 | 75,934 | 20,336 | Sep 09, 2021, 05:07 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Sep 08, 2021 | Sale | $130.00 | 6 | 780 | 20,330 | Sep 09, 2021, 05:07 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Sep 09, 2021 | Sale | $130.00 | 1,407 | 182,910 | 18,923 | Sep 09, 2021, 05:07 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Jul 01, 2021 | Sale | $80.88 | 115,628 | 9,352,391 | 156,264 | Jul 02, 2021, 09:15 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Jul 02, 2021 | Sale | $81.00 | 84,372 | 6,834,551 | 140,636 | Jul 02, 2021, 09:15 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Jun 07, 2021 | Option Exercise | $126.69 | 108 | 13,683 | 20,923 | Jun 08, 2021, 06:53 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | EVP, Chief Commercial Officer | Feb 12, 2021 | Option Exercise | $130.87 | 887 | 116,082 | 18,509 | Jun 08, 2021, 06:48 PM |
XLRN | | ACCELERON PHARMA INC | MCCOURT Thomas A | Director | Apr 19, 2021 | Sale | $79.93 | 15,000 | 1,199,000 | 13,544 | Apr 21, 2021, 04:46 PM |
XLRN | | ACCELERON PHARMA INC | Zakrzewski Joseph S | Director | Apr 05, 2021 | Sale | $82.42 | 20,000 | 1,648,443 | 44,499 | Apr 05, 2021, 08:27 PM |
XLRN | | ACCELERON PHARMA INC | Smith Karen L. | Director | Apr 05, 2021 | Sale | $97.48 | 20,789 | 2,026,561 | 13,486 | Apr 05, 2021, 08:17 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | EVP, Chief Commercial Officer | Mar 02, 2021 | Sale | $88.31 | 10,000 | 883,109 | 24,396 | Mar 04, 2021, 05:17 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | EVP, Chief Commercial Officer | Jan 04, 2021 | Option Exercise | $40.61 | 10,000 | 406,100 | 13,987 | Feb 02, 2021, 07:35 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Jan 04, 2021 | Option Exercise | $124.31 | 942 | 117,100 | 18,219 | Jan 06, 2021, 07:12 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Jan 05, 2021 | Sale | $122.56 | 2,056 | 251,988 | 16,319 | Jan 06, 2021, 07:12 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | EVP, Chief Commercial Officer | Jan 04, 2021 | Sale | $125.25 | 11,357 | 1,422,448 | 13,987 | Jan 06, 2021, 07:09 PM |
XLRN | | ACCELERON PHARMA INC | Backstrom Jay T. | EVP, Research and Development | Jan 04, 2021 | Option Exercise | $124.31 | 1,735 | 215,678 | 15,372 | Jan 06, 2021, 07:05 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jan 05, 2021 | Sale | $121.40 | 1,499 | 181,982 | 6,612 | Jan 06, 2021, 07:03 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jan 04, 2021 | Sale | $124.12 | 3,904 | 484,562 | 10,592 | Jan 06, 2021, 07:03 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Jan 04, 2021 | Option Exercise | $124.31 | 3,278 | 407,488 | 86,046 | Jan 06, 2021, 06:58 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Jan 05, 2021 | Sale | $121.13 | 4,258 | 515,774 | 83,546 | Jan 06, 2021, 06:58 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Dec 14, 2020 | Option Exercise | $81.21 | 85,056 | 6,907,753 | 53,744 | Dec 15, 2020, 06:24 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Dec 09, 2020 | Sale | $80.79 | 7,744 | 625,653 | 15,088 | Dec 11, 2020, 06:08 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Dec 10, 2020 | Sale | $79.35 | 1,000 | 79,352 | 11,716 | Dec 11, 2020, 06:08 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Dec 11, 2020 | Sale | $83.10 | 6,200 | 515,220 | 14,316 | Dec 11, 2020, 06:08 PM |
XLRN | | ACCELERON PHARMA INC | Kearney Terrence C | Director | Oct 12, 2020 | Sale | $73.99 | 75,000 | 5,549,356 | 42,627 | Oct 13, 2020, 07:14 PM |
XLRN | | ACCELERON PHARMA INC | MCCOURT Thomas A | Director | Sep 11, 2020 | Sale | $61.49 | 46,544 | 2,861,782 | 27,694 | Sep 15, 2020, 04:51 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Sep 08, 2020 | Sale | $89.50 | 2,000 | 179,004 | 20,090 | Sep 09, 2020, 05:49 PM |
XLRN | | ACCELERON PHARMA INC | BRISTOL MYERS SQUIBB CO | 10% Owner | Jul 09, 2020 | Sale | $11.12 | 41,220 | 458,406 | 7,010,751 | Jul 13, 2020, 06:27 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Jul 01, 2020 | Sale | $65.72 | 100,000 | 6,572,445 | 139,324 | Jul 06, 2020, 06:57 PM |
XLRN | | ACCELERON PHARMA INC | CELGENE CORP /DE/ | 10% Owner | Jul 01, 2020 | Buy | $92.50 | 108,108 | 9,999,990 | 6,971,772 | Jul 06, 2020, 05:24 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | SVP, General Counsel and Sec. | Apr 08, 2020 | Sale | $56.78 | 12,000 | 681,329 | 27,161 | Apr 10, 2020, 05:30 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Apr 08, 2020 | Sale | $59.13 | 73,548 | 4,348,743 | 47,990 | Apr 10, 2020, 05:29 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Apr 09, 2020 | Option Exercise | $64.70 | 34,452 | 2,228,872 | 28,442 | Apr 10, 2020, 05:29 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | EVP, Chief Commercial Officer | Feb 13, 2020 | Sale | $94.10 | 595 | 55,987 | 15,349 | Feb 14, 2020, 05:02 PM |
XLRN | | ACCELERON PHARMA INC | Zakrzewski Joseph S | Director | Jan 07, 2020 | Option Exercise | $3.88 | 18,750 | 72,750 | 31,500 | Jan 09, 2020, 04:36 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | VP, General Counsel and Sec. | Jan 02, 2020 | Sale | $52.83 | 434 | 22,928 | 15,667 | Jan 03, 2020, 09:51 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | VP, General Counsel and Sec. | Jan 03, 2020 | Sale | $51.23 | 875 | 44,826 | 14,792 | Jan 03, 2020, 09:51 PM |
XLRN | | ACCELERON PHARMA INC | KANGO SUJAY | SVP, Chief Commercial Officer | Jan 03, 2020 | Sale | $51.37 | 480 | 24,656 | 9,581 | Jan 03, 2020, 09:48 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | EVP, Chief Business Officer | Jan 02, 2020 | Sale | $52.52 | 5,842 | 306,806 | 57,558 | Jan 03, 2020, 09:45 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jan 02, 2020 | Sale | $52.50 | 5,579 | 292,923 | 8,713 | Jan 03, 2020, 09:41 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Jan 03, 2020 | Sale | $51.24 | 3,732 | 191,230 | 70,785 | Jan 03, 2020, 09:37 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Dec 13, 2019 | Sale | $50.28 | 11,853 | 595,969 | 10,426 | Dec 17, 2019, 06:39 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | VP, General Counsel and Sec. | Sep 10, 2019 | Sale | $45.20 | 824 | 37,241 | 16,124 | Sep 10, 2019, 08:25 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Sep 10, 2019 | Sale | $45.24 | 3,389 | 153,318 | 86,986 | Sep 10, 2019, 08:24 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | EVP, Chief Business Officer | Sep 10, 2019 | Sale | $45.23 | 3,584 | 162,104 | 59,158 | Sep 10, 2019, 08:23 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Sep 10, 2019 | Sale | $45.30 | 8,000 | 362,400 | 22,452 | Sep 10, 2019, 08:22 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Sep 10, 2019 | Sale | $45.23 | 5,625 | 254,412 | 71,227 | Sep 10, 2019, 08:21 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | VP, General Counsel and Sec. | Aug 09, 2019 | Sale | $45.00 | 3,268 | 147,060 | 16,925 | Aug 12, 2019, 04:18 PM |
XLRN | | ACCELERON PHARMA INC | Veness Adam M | VP, General Counsel and Sec. | Jul 16, 2019 | Sale | $40.71 | 538 | 21,902 | 20,193 | Jul 17, 2019, 05:49 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | EVP, Chief Business Officer | Jul 09, 2019 | Option Exercise | $4.82 | 8,908 | 42,908 | 62,742 | Jul 11, 2019, 04:26 PM |
XLRN | | ACCELERON PHARMA INC | George Jean | Director | Jun 26, 2019 | Sale | $31.56 | 63,188 | 1,994,117 | 41,250 | Jun 28, 2019, 07:25 PM |
XLRN | | ACCELERON PHARMA INC | George Jean | Director | Jun 28, 2019 | Sale | $41.17 | 11,812 | 486,300 | 0 | Jun 28, 2019, 07:25 PM |
XLRN | | ACCELERON PHARMA INC | Zakrzewski Joseph S | Director | Jun 14, 2019 | Buy | $38.05 | 5,000 | 190,250 | 12,750 | Jun 17, 2019, 06:08 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Apr 09, 2019 | Sale | $44.64 | 3,622 | 161,671 | 90,545 | Apr 11, 2019, 04:58 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | EVP, CBO and Secretary | Apr 09, 2019 | Sale | $44.64 | 3,622 | 161,671 | 54,004 | Apr 11, 2019, 04:58 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Apr 09, 2019 | Sale | $44.62 | 12,000 | 535,405 | 30,379 | Apr 11, 2019, 04:58 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Apr 09, 2019 | Sale | $44.60 | 7,460 | 332,748 | 76,754 | Apr 11, 2019, 04:58 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Apr 02, 2019 | Sale | $48.02 | 648 | 31,117 | 42,279 | Apr 04, 2019, 06:07 PM |
XLRN | | ACCELERON PHARMA INC | CELGENE CORP /DE/ | 10% Owner | Jan 18, 2019 | Buy | $43.00 | 706,206 | 30,366,858 | 6,824,685 | Jan 22, 2019, 05:00 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Jan 02, 2019 | Sale | $42.94 | 5,788 | 248,546 | 93,572 | Jan 04, 2019, 06:36 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | EVP, CBO and Secretary | Jan 02, 2019 | Sale | $42.83 | 5,942 | 254,490 | 57,289 | Jan 04, 2019, 06:35 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jan 02, 2019 | Sale | $42.80 | 5,712 | 244,494 | 42,527 | Jan 04, 2019, 06:34 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Jan 03, 2019 | Sale | $43.41 | 1,957 | 84,961 | 66,295 | Jan 04, 2019, 06:34 PM |
XLRN | | ACCELERON PHARMA INC | Dable Habib J | CEO and President | Dec 04, 2018 | Sale | $52.99 | 12,675 | 671,610 | 78,394 | Dec 06, 2018, 04:22 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Aug 30, 2018 | Option Exercise | $40.98 | 25,000 | 1,024,625 | 56,439 | Aug 31, 2018, 07:00 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jun 29, 2018 | Option Exercise | $36.06 | 50,000 | 1,802,750 | 68,939 | Jul 03, 2018, 02:32 PM |
XLRN | | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Apr 03, 2018 | Sale | $38.40 | 3,500 | 134,395 | 26,458 | Apr 04, 2018, 04:41 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Apr 03, 2018 | Sale | $38.41 | 1,203 | 46,205 | 96,035 | Apr 04, 2018, 04:40 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | SVP, Corp. Dev., GC & Sec. | Apr 03, 2018 | Sale | $38.40 | 1,204 | 46,232 | 56,698 | Apr 04, 2018, 04:40 PM |
XLRN | | ACCELERON PHARMA INC | Sherman Matthew L | EVP & Chief Medical Officer | Apr 03, 2018 | Sale | $38.43 | 4,600 | 176,772 | 69,667 | Apr 04, 2018, 04:39 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Apr 03, 2018 | Sale | $38.45 | 4,000 | 153,792 | 44,739 | Apr 04, 2018, 04:38 PM |
XLRN | | ACCELERON PHARMA INC | Maniatis Tom | Director | Mar 21, 2018 | Option Exercise | $5.08 | 18,750 | 95,250 | 135,481 | Mar 23, 2018, 05:48 PM |
XLRN | | ACCELERON PHARMA INC | POPS RICHARD F | Director | Mar 06, 2018 | Sale | $23.25 | 75,000 | 1,743,594 | 68,750 | Mar 08, 2018, 04:11 PM |
XLRN | | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Jan 12, 2018 | Option Exercise | $34.56 | 22,000 | 760,210 | 35,701 | Jan 17, 2018, 05:14 PM |
XLRN | | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Jan 02, 2018 | Sale | $42.41 | 1,433 | 60,774 | 25,534 | Jan 04, 2018, 07:05 PM |
XLRN | | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Jan 03, 2018 | Sale | $42.45 | 833 | 35,361 | 24,701 | Jan 04, 2018, 07:05 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Jan 02, 2018 | Sale | $42.41 | 4,300 | 182,363 | 92,675 | Jan 04, 2018, 07:04 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | SVP, Corp. Dev., GC & Sec. | Jan 02, 2018 | Sale | $42.42 | 4,333 | 183,806 | 52,977 | Jan 04, 2018, 07:03 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jan 02, 2018 | Sale | $42.42 | 4,000 | 169,680 | 45,300 | Jan 04, 2018, 07:03 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jan 03, 2018 | Option Exercise | $4.58 | 12,501 | 57,254 | 57,801 | Jan 04, 2018, 07:03 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Jan 04, 2018 | Sale | $43.01 | 15,000 | 645,168 | 43,001 | Jan 04, 2018, 07:03 PM |
XLRN | | ACCELERON PHARMA INC | Sherman Matthew L | EVP & Chief Medical Officer | Jan 03, 2018 | Sale | $42.71 | 4,633 | 197,868 | 77,700 | Jan 04, 2018, 07:02 PM |
XLRN | | ACCELERON PHARMA INC | George Jean | Director | Dec 15, 2017 | Sale | $35.73 | 105,122 | 3,756,009 | 0 | Dec 18, 2017, 04:53 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Sep 28, 2017 | Option Exercise | $5.28 | 6,761 | 35,698 | 96,975 | Sep 29, 2017, 04:13 PM |
XLRN | | ACCELERON PHARMA INC | CELGENE CORP /DE/ | 10% Owner | Sep 25, 2017 | Buy | $37.00 | 745,592 | 27,586,904 | 6,118,479 | Sep 25, 2017, 04:23 PM |
XLRN | | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Sep 12, 2017 | Sale | $38.41 | 14,000 | 537,786 | 28,232 | Sep 14, 2017, 05:04 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Sep 12, 2017 | Sale | $38.42 | 5,105 | 196,113 | 90,722 | Sep 14, 2017, 05:03 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Sep 13, 2017 | Sale | $38.12 | 8 | 305 | 90,214 | Sep 14, 2017, 05:03 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | SVP, Corp. Dev., GC & Sec. | Sep 12, 2017 | Sale | $38.42 | 5,105 | 196,118 | 57,918 | Sep 14, 2017, 05:03 PM |
XLRN | | ACCELERON PHARMA INC | Quisel John D | SVP, Corp. Dev., GC & Sec. | Sep 13, 2017 | Sale | $38.03 | 8 | 304 | 57,310 | Sep 14, 2017, 05:03 PM |
XLRN | | ACCELERON PHARMA INC | Sherman Matthew L | EVP & Chief Medical Officer | Sep 12, 2017 | Sale | $38.41 | 18,400 | 706,798 | 79,750 | Sep 14, 2017, 05:02 PM |
XLRN | | ACCELERON PHARMA INC | MCLAUGHLIN KEVIN F | SVP, CFO and Treasurer | Sep 12, 2017 | Sale | $38.41 | 16,000 | 614,546 | 50,810 | Sep 14, 2017, 05:02 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Aug 08, 2017 | Option Exercise | $29.76 | 26,130 | 777,629 | 108,392 | Aug 09, 2017, 04:32 PM |
XLRN | | ACCELERON PHARMA INC | Kumar Ravindra | SVP & Chief Scientific Officer | Jul 05, 2017 | Option Exercise | $19.56 | 1,874 | 36,655 | 96,264 | Jul 07, 2017, 04:57 PM |